PT Bundamedik Tbk

bmhs

Overview

BMHS Overview

PT Bundamedik Tbk is an Indonesia-based company, which is engaged in hospital management. The Company’s segments include Healthcare services and Others. The Company is a health care service provider that has medical technology at Bunda Jakarta Woman and Children Hospital, Bunda Jakarta General Hospital , Bunda Margonda General Hospital , Bunda Padang General Hospital, Bunda Ciputat Woman and Children Hospital, Bunda Citra Harapan General Hospital, AZ Zahra Woman and Children Hospital, BIC Pacific Place & BIC Vida Bekasi, Morula IVF (In Vitro Fertilization) Indonesia, Diagnos (Laboratory), Bunda Global Pharma, Emergency Response (ER), Bunda Diklat Indonesia, IRSI (Indonesian Reproductive Sciences Institute), Prima Dental, Indonesia Medical Tourism Board (IMTB) and Daima Norwood Menteng. Its subsidiaries include T Citra Ananda, PT Bunda Medika Wisesa, PT Visiscan Indonesia, PT Bunda Medika Dewata, and PT Sasana Mitra Bunda.

1.02.03.04.05.06.07.0ValueCompetitiveFutureFinancialsDividend
Exchange
Indonesia Stock Exchange

Symbol: BMHS

Main
Market Cap.
IDR 2.77Trillion

~$173.13M USD

Industry
Healthcare Providers
Sub-Industry
Healthcare Providers
Sector
Healthcare

Valuation

BMHS Valuation Metrics

322

IDR
0.0%

Closing Price on 2024-04-18

Price to Equity

110.82

P/E

At 110.82x P/E TTM, BMHS.JK is trading at a premium to its peers in the Healthcare Equipment & Providers sector (avg 16.9x).

Price to Book

1.74

P/B

At 1.74x P/B TTM, BMHS.JK is trading in line with its peers in the Healthcare Equipment & Providers sector.

Price to Sales

1.86

P/S

At 1.86x P/S TTM, BMHS.JK is trading at a discount to its peers in the Healthcare Equipment & Providers sector.

Valuing PT Bundamedik Tbk based on its trailing twelve months (TTM) valuation metrics against its peers in the Healthcare Equipment & Providers sector

Historical Price to Earnings

Other Valuation Metrics

Valuing PT Bundamedik Tbk relative to other stocks in the Healthcare Equipment & Providers sector

Price/Cash Flow
53.86x
Price/Forward Earnings
-
Enterprise Value/Revenue
2.50x
Enterprise Value/EBITDA
18.25x
PEG Ratio
-1.23x

Analyst Ratings

40
60
80
0
100

100.0

Undervalued

Fairly Valued

Overvalued

Last closing: IDR3222024-04-18
IDR 58.34

Considerably Lower Intrinsic Value: Analyst's intrinsic value is of BMHS is IDR58, which is 81% lower than BMHS's last closing price of IDR322 (as of 2024-04-18).

Valuation Recap of BMHS stock
WeightNotesScore
High
The P/E ratio is calculated by dividing the market price of a company's stock by its earnings per share (EPS). It is a key tool for investors and analysts to assess whether a stock is overvalued, undervalued, or fairly valued. A P/E ratio of 110.82x is above the ID market average of 8.46x and is trading at a premium to peers in the Healthcare Equipment & Providers sector (16.91x). In fact, less than 25% of its peers trade at a higher P/E ratio than BMHS.

High
The P/B ratio is calculated by dividing the market price of a company's stock by its book value per share (BVPS). It measures the company's stock value relative to its assets minus liabilities. A P/B ratio of 1.74x is similar to the peers average of 1.69x in the Healthcare Equipment & Providers sector.

Medium
The P/S ratio is calculated by dividing the market price of a company's stock by its sales per share. It measures the company's stock value relative to its sales. A P/S ratio of 1.86x is below the peers average of 2.87x in the Healthcare Equipment & Providers sector. When considered alongside the Forward Price/Earnings ratio, they serve to illustrate investors' expectations of BMHS's valuation relative to its current sales and future earnings growth.

Low
The Price/Cash Flow ratio (P/CF) is calculated by dividing the market price of a company's stock by its cash flow per share. It measures the company's stock value relative to its cash flow, and is sometimes said to be a more objective measure of a company's value because cash flows cannot be manipulated as easily as earnings, which considers non-cash items such as depreciation and amortization. BMHS's P/CF ratio of 53.86x is considered a relatively high ratio by analysts.

Low
The Enterprise Value/Revenue ratio (EV/R) is calculated by dividing the enterprise value of a company by its revenue. It measures the company's enterprise value relative to its revenue. It is an indicator of how much it costs to buy the company's revenue; the lower the ratio, the cheaper the company's revenue. BMHS's EV/R ratio of 2.50x is considered fairly underpriced by the market The average EV/R ratio for the Healthcare Equipment & Providers sector is 2.95x.

Medium
Considerably Lower Intrinsic Value: Analyst's intrinsic value is of BMHS is IDR 58.34, which is 81% lower than BMHS's last closing price of IDR 322.00.

Peers

BMHS Peers and Comparison

Peer Companies

Supertype Fuzzy Search
SymbolCompany Name
Market Cap
(in Trillion IDR)
Total Assets
(in Trillion IDR)
Total Revenue
(in Trillion IDR)
Profit and Loss
(in Trillion IDR)
P/E
P/B
KLBFKalbe Farma Tbk65.45T27.06T 30.45T 2.77T 23.663.06
MIKAPT Mitra Keluarga Karyasehat Tbk.36.85T7.34T 4.26T 0.92T 40.236.33
SILOPT Siloam International Hospitals Tbk.31.10T10.98T 11.19T 1.21T 25.683.93
SRAJSejahteraraya Anugrahjaya Tbk20.58T5.61T 2.50T -0.04T -534.7211.09
SIDOPT Industri Jamu Dan Farmasi Sido Muncul Tbk19.95T3.89T 3.57T 0.95T 20.995.89
HEALPT Medikaloka Hermina Tbk.16.86T8.80T 5.78T 0.44T 38.544.36
PRAYPT Famon Awal Bros Sedaya Tbk9.56T4.70T 1.84T 0.22T 44.073.42
TSPCTempo Scan Pacific Tbk8.66T11.32T 13.12T 1.18T 7.351.12
SOHOPT Soho Global Health Tbk6.24T4.75T 8.20T 0.37T 16.822.60
OMEDPT Jayamas Medica Industri Tbk5.33T2.58T 1.74T 0.26T 20.552.40
Competitiveness Recap of BMHS stock
WeightNotesScore
High
At a market cap of IDR 2,770.30 billion, BMHS.JK ranks 10 in Market Cap out of 10 companies in the Healthcare sector.

High
At a PE of 110.82, BMHS.JK ranks 1 out of 10 companies in the Healthcare sector for P/E value. The average PE is -20.66 (unadjusted). A high P/E ratio often indicates higher growth expectation, or other qualitative factors that led investors to believe that the company has a defensible competitive advantage compared to its peers in Healthcare. false

Medium
At a PE of 110.82, BMHS.JK is trading at a higher PE than that of its subsector peers in Healthcare Equipment & Providers (median of 16.91). false

Medium
At a revenue of IDR 1.49 trillion, BMHS.JK ranks 10 in Revenue out of 10 companies in the Healthcare sector.

Medium
At a profit of IDR 0.02 trillion, BMHS.JK ranks 9 in Profit out of 10 companies in the Healthcare sector.

Future

Future Growth of BMHS

Growth Forecasts

No data available

Sector Benchmark

Healthcare Equipment & Providers companies in Indonesia are growing at a projected rate of 9.82% against the IDX average of +7.6%.

Healthcare Equipment & Providers sector overview
No data is available for BMHS at the moment.
Future growth prospect of BMHS
WeightNotesScore
High
BMHS's projected growth rate of 9.82% is above the ID market average of 7.62%.

Medium
BMHS and its peers in the Healthcare Equipment & Providers sub-sector belongs to the Healthcare sector. Companies in the Healthcare sector are projected to have a challenging year heading into 2024. Specifically, earnings are projected to decrease by 0.00% in 2024 while revenue growth is projected to decrease by -5.79%. These macroeconomic trends will likely be a headwind for BMHS's earnings growth prospects in the next 2 years.

Loading...
Loading...

Management

Executive Management

President Director

Mesha Rizal Sini15.2 years
Tedy Homogin
Director
Nurhadi Yudiyantho
Director
Cuncun Wijaya
Director
Emilia Rouli
Director
Ivonne Rampun
Director
NamePositionShares%
Ivan Rizal SiniPresident Commissioner278,600,0003.24
Mesha Rizal SiniPresident Director278,600,0003.24
Rito Alam Rizal SiniCommissioner278,600,0003.24
Expressed in millions IDR, unless otherwise stated

Ownership

BMHS Ownership

Others
21.47%
Insiders
78.53%
Institutions
0%
NameNumber of SharesOwnership (%)Value
Pt Bunda Investama Indonesia4,935,430,90057.371,589.21B
Public (Scripless)2,376,534,27627.61765.24B
Ivan Rizal Sini278,600,0003.2489.71B
Mesha Rizal Sini278,600,0003.2489.71B
Rito Alam Rizal Sini278,600,0003.2489.71B
Renobulan Rizal Sini Suheimi207,786,0002.4266.91B
Ietje Ika S. Rizal Sini157,865,0001.8350.83B
Public (Scrip)90,000,0001.0528.98B
No data is available for BMHS at the moment.